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Abstract. As very large studies of complex neuroimaging phenotypes
become more common, human quality assessment of MRI-derived data
remains one of the last major bottlenecks. Few attempts have so far
been made to address this issue with machine learning. In this work,
we optimize predictive models of quality for meshes representing deep
brain structure shapes. We use standard vertex-wise and global shape
features computed homologously across 19 cohorts and over 7500 human-
rated subjects, training kernelized Support Vector Machine and Gradient
Boosted Decision Trees classifiers to detect meshes of failing quality. Our
models generalize across datasets and diseases, reducing human workload
by 30-70%, or equivalently hundreds of human rater hours for datasets
of comparable size, with recall rates approaching inter-rater reliability.
Keywords: shape analysis, machine learning, quality control
1 Introduction
In recent years, large-scale neuroimaging studies numbering in the thousands
and even 10’s of thousands of subjects have become a reality [1]. Though auto-
mated MRI processing tools [2] have become sufficiently mature to handle large
datasets, visual quality control (QC) is still required. For simple summary mea-
sures of brain MRI, QC may be a relatively quick process. For more complex
measures, as in large studies of voxel- and vertex-wise features [3], the QC process
becomes more time-intensive for the human raters. Both training of raters and
conducting QC ratings, once trained, can take hours even for modest datasets.
This issue is particularly relevant in the context of multi-site meta-analyses,
exemplified by the ENIGMA consortium [1]. Such studies, involving dozens of
institutions, require multiple researchers to perform quality control on their co-
horts, as individual data cannot always be shared. In addition, for meta-analysis
studies performed after data collection, the QC protocols must be reliable in
spite of differences in scanning parameters, post-processing, and demographics.
In effect, QC has become one of the main practical bottlenecks in big-data neu-
roimaging. Reducing human rater time via predictive modeling and automated
quality control is bound to play an increasingly important role in maintaining
and hastening the pace of the scientific discovery cycle in this field.
In this paper, we train several predictive models for deep brain structure
shape model quality. Our data is comprised of the ENIGMA Schizophrenia and
Major Depressive Disorder working groups participating in the ENIGMA-Shape
project [3]. Using ENIGMA’s Shape protocol and rater-labeled shapes, we train
a discriminative model to separate “FAIL”(F) and “PASS”(P) cases. For classi-
fication, we use a support vector classifier with a radial basis kernel (SVC) and
Gradient Boosted Decision Trees (GBDT). Features are derived from the stan-
dard vertex-wise measures as well as global features. For six out of seven deep
brain structures, we are able to reduce human rater time by 30 to 70 percent in
? these authors contributed equally
out-of-sample validation, while maintaining FAIL recall rates similar to human
inter-rater reliability. Our models generalize across datasets and disease samples.
2 Methods
Our goal in using machine learning for automated QC differs somewhat from
most predictive modeling problems. Typical two-class discriminative solutions
seek to balance misclassification rates of each class. In the case of QC, we focus
primarily on correctly identifying FAIL cases, by far the smaller of the two
classes (Table 1). In this first effort to automate shape QC, we do not attempt
to eliminate human involvement, but simply to reduce it by focusing human
rater time on a smaller subsample of the data containing nearly all failing cases.
Our quality measures, described below, reflect this nuance.
2.1 MRI processing and shape features
Our deep brain structure shape measures are computed using a previously de-
scribed pipeline [4,5], available via the ENIGMA Shape package. Briefly, struc-
tural MR images are parcellated into cortical and subcortical regions using
FreeSurfer. Among the 19 cohorts participating in this study, FreeSurfer ver-
sions 5.1 and 5.3 were used, depending on the institution. The binary region of
interest (ROI) images are then surfaced with triangle meshes and parametrically
(spherically) registered to a common region-specific surface template [6]. This
leads to a one-to-one surface correspondence across the dataset at roughly 2,500
vertices per ROI. Our ROIs include the left and right thalamus, caudate, puta-
men, pallidum, hippocampus, amygdala, and nucleus accumbens. Each vertex p
of mesh model M is endowed with two shape descriptors:
Medial Thickness, D(p) = ‖cp−p‖, where cp is the point on the medial curve
c closest to p.
LogJac(p), Log of the Jacobian determinant J arising from the template
mapping, J : Tφ(p)Mt → TpM .
Since the ENIGMA surface atlas is in symmetric correspondence, i.e. the left
and right shapes are vertex-wise symmetrically registered, we can combine two
hemispheres for each region for the purposes of predictive modeling. At the cost
of assuming no hemispheric bias in QC failure, we effectively double our sample.
The vertex-wise features above are augmented with their volume-normalized
counterparts: {D,J}normed(p) = {D,J}(p)
V {
1
3
, 2
3
} . Given discrete area elements of the
template at vertex p,At(p), we estimate volume as V =
∑
p∈vrts(M)
3At(p)J(p)D(p).
We also use two global features: the shape-wide feature median, and the shape-
wise 95th percentile feature threshold.
2.2 Human quality rating
Human-rated quality control of shape models is performed following the ENIGMA-
Shape QC protocol44. Briefly, raters are provided with several snapshots of each
region model as well as its placement in several anatomical MR slices (Fig. 1).
A guide with examples of FAIL (QC=1) and PASS (QC=3) cases is provided
to raters, with an additional category of MODERATE PASS (QC=2) suggested
for inexperienced raters. Cases from the last category are usually referred to
more experienced raters for second opinions. Once a rater becomes sufficiently
experienced, he or she typically switches to the binary FAIL/PASS rating. In
this work, all remaining QC=2 cases are treated as PASS cases, consistent with
ENIGMA shape studies.
Fig. 1. Example hippocampal shape snapshots used for human QC rating
Left: A mesh passing visual QC. Right: A mesh failing visual QC.
2.3 Predictive models
First, we used Gradient Boosted Decision Trees (GBDT). This is a powerful
ensemble learning method introduced by Friedman [7] in which subsequent trees
correct for the errors of the previous trees. In our experiments we used the
Xgboost [8] implementation due to speed and regularization heuristics, with
the logistic loss function. Second, we used Support Vector Classifier. Based on
earlier experiments and the clustered nature of FAIL cases in our feature space,
we used the radial basis function (RBF) kernel in our SVC models. Indeed, in
preliminary experiments RBF outperformed linear and polynomial kernels. We
used scikit-learn’s [9] implementation of SVC.
44 enigma.usc.edu/ongoing/enigma-shape-analysis
2.4 Quality measures
In describing our quality measures below, we use the following definitions. TF
stands for TRUE FAIL, FF stands for FALSE FAIL, TP stands for TRUE PASS,
and FP stands for FALSE PASS. Our first measure, F-recall = TFTF+FP , shows
the proportion of FAILS that are correctly labeled by the predictive model. The
second measure, F-share = TF+FFNumber of observations , shows the proportion of the
test sample labeled as FAIL by the model. Finally, we used a modified F-
score, which allows us to compare models based on the specific requirements of
our task, i.e. a very high F-recall and F-share substantially below 1, we use a
variation on the standard F-score.
F-scoremod = 2× F-recall× (1− F-share)
F-recall + (1− F-share) .
Note that the modified F-score cannot equal 1, as in the standard case. An ideal
prediction leads to F-scoremod = 1 - F-share. The intuition behind our custom
F-score is based on the highly imbalanced FAIL and PASS samples. A model
that accurately labels all failed cases is only valuable if it substantially reduces
the workload for human raters, a benefit reflected by F-share.
3 Experiments
For each of the seven ROIs, we performed eight experiments defined by two
predictive models (SVC and GBDT), two types of features (original and normed)
and two cross-validation approaches. We tested ”Leave-One-Site-Out” and 5-fold
stratified cross-validation, as described below.
3.1 Datasets
In our experiments, we used deep brain structure shape data from the ENIGMA
Schizophrenia and Major Depressive Disorder working groups.
FAIL % accumbens caudate hippocampus thalamus putamen pallidum amygdala
Train mean±std 3.4±4.7 0.9±0.7 2.0±1.1 0.8±1.0 0.6±0.6 2.3±3.6 0.9±0.9
max 16.4 2.1 4.2 3.4 1.5 13.8 2.6
min 0.0 0.0 0.5 0.0 0.0 0.0 0.0
size 10431 10433 10436 10436 10436 10435 10436
Test mean±std 4.7±4.5 1.4±1.5 4.9±4.8 1.4±1.5 0.4±0.8 1.9±2.0 0.8±0.9
max 10.5 3.5 11.4 3.5 1.6 3.8 2.1
min 0.0 0.0 0.0 0.0 0.0 0.0 0.0
size 3017 3018 3018 3018 3017 3018 3018
Table 1. Overview of FAIL percentage mean, standard deviation, maximum and min-
imum for each site. Sample sizes for each ROI vary slightly due to FreeSurfer segmen-
tation failure.
Our predictive models were trained using 15 cohorts totaling 5718 subjects’
subcortical shape models from the ENIGMA-Schizophrenia working group. The
ENIGMA-Schizophrenia (ENIGMA-SCZ) working group is comprised of over
two dozen cohorts from around the world. The goal of the working group is
to identify subtle effects of Schizophrenia and related clinical factors on brain
imaging features. For a complete overview of ENIGMA-SCZ projects and cohort
details, see [10].
To test our final models, we used data from 4 cohorts in the Major Depressive
disorder working group (ENIGMA-MDD), totaling 1509 subjects, for final out-
of-fold testing. A detailed description of the ENIGMA-MDD sites and clinical
questions can be found here [11].
3.2 Model validation
All experiments were performed separately for each ROI. The training dataset
was split into two halves referred to as ’TRAIN GRID’ and ’TRAIN EVAL.’
The two halves contained data from each ENIGMA-SCZ cohort, stratified by the
cohort-specific portion of FAIL cases. Model parameters were optimized using
a grid search within ’TRAIN GRID’, with either stratified 5-fold or Leave-One-
Site-Out cross-validation. Parameters yielding the highest Area Under the ROC-
curve were selected from among all cross-validation and feature types.
Both SVC and GBDT produce probability estimates indicating the likelihood
that the individual subject’s ROI mesh is a FAIL case, PFAIL. Exploiting this,
we sought a probability threshold for each model selected during the grid search
to optimize the modified F-score in the ’TRAIN EVAL’ sample. This amounts
to a small secondary grid search. To simplify traversing this parameter space, we
instead sample F-scoremod at regularly spaced values of PFAIL, from 0.1 to 0.9
in 0.1 increments. This is equivalent to F-share in the ’TRAIN EVAL’ sample
(Eval F-share, Table 2).
Final thresholds (Thres in Table 2) were selected based on the highest
F-scoremod, requiring that F-recall ≥ 0.8 - a minimal estimate of inter-rater
reliability. It is important to stress that while we used sample distribution in-
formation in selecting a threshold, the final out-of-sample prediction is made on
an individual basis for each mesh.
4 Results
Trained models were deliberately set to use a loose threshold for FAIL detection,
predicting 0.3-0.8 of observations as FAILs in the TRAIN GRID sample. These
predicted FAIL observations contained 0.85-0.9 of all true FAILs, promising to
reduce the human rater QC time by 20-70%. These results largely generalized
to the ’TRAIN EVAL’ and test samples: Table 2 shows our final model and
threshold performance for each ROI.
With the exception of the thalamus, our final models’ performance measures
generalized to the test sample, in some cases having better sample F-recall and
lower percentage of images still requiring human rating compared to the evalu-
ation sample. A closer look suggests that variability in model predictions across
sites generally follows human rater differences. Table 3 breaks down perfor-
mance by test cohort. It is noteworthy that the largest cohort, Mu¨nster (N =
1033 subjects, 2066 shape samples), has the best QC prediction performance.
ROI Model CV Features Thres
Eval
F-recall
Eval
F-share
Eval
F-score
Test
F-recall
Test
F-share
Test
F-score
Accumbens GBDT 5-fold Normed 0.014 0.83 0.2 0.81 0.75 0.27 0.74
Amygdala GBDT 5-fold Normed 0.007 0.89 0.4 0.72 0.76 0.40 0.67
Caudate SVC LOSO Original 0.017 0.84 0.3 0.76 0.92 0.45 0.68
Hippocampus GBDT 5-fold Normed 0.010 0.85 0.2 0.83 0.91 0.29 0.80
Pallidum GBDT 5-fold Normed 0.009 0.86 0.2 0.83 0.86 0.30 0.77
Putamen SVC LOSO Normed 0.007 0.84 0.4 0.70 0.65 0.44 0.60
Thalamus SVC LOSO Original 0.007 0.84 0.4 0.70 1.00 1.00 0.00
Table 2. Test performance of the models with the best F-scoremod on evaluation
(TRAIN EVAL). Excepting the thalamus, overall models’ performance generalizes to
out-of-sample test data
At the same time, the ”cleanest” dataset, Houston, with no human-detected
quality failures, has the lowest F-share. In other words, Houston would require
the least human rater time relative to its size, as would be hoped.
Visualizing the test results in Figure 2, we see the trend for lower F-share
with higher overall dataset quality maintained by the smaller cohorts, but re-
versed by Mu¨nster. This could be a reflection of our current models’ bias toward
accuracy in lower-quality data due to greater numbers of FAIL examples (i.e.,
FAILs in high and low quality datasets may be qualitatively different). At the
same time, F-recall appears to be independent of QC workload reduction due to
ML, with most rates above the 0.8 mark.
5 Conclusion
We have presented a preliminary study of potential machine learning solutions
for semi-automated quality control of deep brain structure shape data. Though
some work on automated MRI QC exists [12], we believe this is the first ML
approach in detecting end-of-the-pipeline feature failure in deep brain structure
geometry. We showed that machine learning can robustly reduce human visual
QC time for large-scale analyses for six out of the seven regions in question,
across diverse MRI datasets and populations. Failure of the thalamus ML QC
ratings to generalize out-of-sample may be explained by the region’s specific fea-
tures. Though we have only used geometry information in model training, MRI
intensity, available to human raters for all ROI’s, plays a particularly important
ROI
Berlin
F-recall
Berlin
F-share
Stanford
F-recall
Stanford
F-share
Munster
F-recall
Munster
F-share
Houston
F-recall
Houston
F-share
Accumbens 0.58 0.21 0.58 0.28 0.88 0.30 - 0.10
Amygdala 1.00 0.36 1.00 0.71 0.74 0.42 - 0.17
Caudate 0.67 0.41 0.88 0.53 0.96 0.51 - 0.16
Hippocampus 0.88 0.21 0.88 0.52 0.92 0.31 - 0.05
Pallidum 1.00 0.23 0.88 0.43 0.86 0.34 - 0.06
Putamen - 0.47 - 0.71 0.65 0.46 - 0.14
Thalamus 1.00 1.00 1.00 1.00 1.00 1.00 - 1.00
Table 3. Performance of best models for each test site. Models are the same as in
Table 2. Symbol ’-’ indicates that there were no FAILs for particular ROI and test site.
Fig. 2. Scatter plots of F-recall and actual FAIL case percentage vs. pro-
portion of predicted FAIL cases on test datasets. Left: F-share vs F-recall.
Right: Fail F-share vs FAIL percentage. Mark size shows the dataset size. Mark shape
represents dataset (site): © - CODE-Berlin (N=176); 2 - Mu¨nster (N=1033);
4 - Stanford (N=105); 5 - Houston (N=195)
.
role in thalamus ratings. The most common thalamus segmentation failure is
the inclusion of lateral ventricle by FreeSurfer. Geometry is generally altered
undetectably in such cases.
Beyond adding intensity-based features, possible areas of future improvement
include combining ML algorithms, exploiting parametric mesh deep learning,
employing geometric data augmentation, and refining the performance measures.
Specifically, mesh-based convolutional neural nets can help visualize problem
areas, which can be helpful for raters.
Very large-scale studies, such as the UK Biobank, ENIGMA, and others, are
becoming more common. To make full use of these datasets, it is imperative
to maximally automate the quality control process that has so far been almost
entirely manual in neuroimaging. Our work here is a step in this direction.
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